Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Search results for: “patient perspective”

  • Oncology Trials Could Benefit From Increased Data on Tobacco Use

    Oncology Trials Could Benefit From Increased Data on Tobacco Use

    By

    Industry News & Regulatory Approvals

    By Leah Lawrence Posted: June 24, 2020 As part of its declaration on tobacco cessation after cancer diagnosis, the IASLC recommended that smoking status, both initially and during the study, should be a required data element for all prospective clinical studies and that these studies should consider designs that could also determine the most effective…

  • Stage IIIA NSCLC: A Review of Recent and Ongoing Trials Trial

    Stage IIIA NSCLC: A Review of Recent and Ongoing Trials Trial

    By

    Evolving Standards of Care

    By Mariano Provencio, MD, PhD Posted: June 24, 2020 Data can help inform change to standard of care, but at what point do we say enough data is enough and move forward with combination therapy as the new standard of care? Stage IIIA disease accounts for approximately 15% to 20% of all lung cancers. This…

  • Lung Cancer in the Brazilian Health System: Screening, Drug Approvals, Barriers to Care, and Success Stories

    Lung Cancer in the Brazilian Health System: Screening, Drug Approvals, Barriers to Care, and Success Stories

    By

    Global Initiatives

    By Ricardo Sales dos Santos, MD, PhD, and Juliana Franceschini, PhD Posted: June 24, 2020 Dr. Juliana Franceschini Dr. Ricardo Sales dos Santos                             The reality of lung cancer in Brazil is as alarming as it is in the rest of the…

  • Multidisciplinary Tumor Board: A Single Institution’s Perspective

    Multidisciplinary Tumor Board: A Single Institution’s Perspective

    By

    Evolving Standards of Care

    By Ari Rosenberg, MD Posted: June 24, 2020   As 7:00 AM approaches, the ninth-floor conference room slowly fills as team members file in and find their seats. The senior radiation oncologist identifies his seat in the front row, carefully placing his stack of index cards on the table before him, each identifying a patient’s…

  • Telehealth Is Not a One-Size-Fits-All Approach

    Telehealth Is Not a One-Size-Fits-All Approach

    By

    Evolving Standards of Care

    By Narjust Duma, MD Posted: June 10, 2020 During the past 8 weeks, we have heard how many of our colleagues and cancer centers are switching to telehealth. Two things are clear during this pandemic. The first is that cancer centers cannot wait—most cancer procedures and treatments are not elective, and our patients need their…

  • Patient, Provider Safety Paramount During Pandemic: Telehealth Benefits Are Numerous

    Patient, Provider Safety Paramount During Pandemic: Telehealth Benefits Are Numerous

    By

    Evolving Standards of Care

      By Mary Jo Fidler, MD Posted: June 10, 2020 Healthcare systems in the United States have been slow to adopt telehealth, in part, due to regulatory limitations, patient privacy concerns, and less reimbursement potential.1 However, at the same time, there has been an enormous effort to incorporate electronic health records (EHR) driven by programs…

  • Telehealth Successes and Challenges

    Telehealth Successes and Challenges

    By

    Evolving Standards of Care

    Posted: June 9, 2020 Across specialties, COVID-19 has resulted in increased patient anxiety and decreased in-person appointments. The rapid uptake of telehealth has, for some, widened disparity gaps and been an obstacle in maintaining patient–physician relationships; for others, telehealth has presented an opportunity to provide consistent long-term care to patients in the safety and comfort…

  • Making Mesothelioma Patient Research Happen: The United Kingdom Experience

    Making Mesothelioma Patient Research Happen: The United Kingdom Experience

    By

    Evolving Standards of Care

    By Liz Darlison, MBE, EN, RN, BSc, MSc; Clare Gardiner, PhD, BSc (hons); Catherine Henshall, MN, RN, MA, PhD; and Angela M. Tod, PhD, MSc, MMedSci, BA (hons), RN Posted: June 9, 2020 The United Kingdom has the highest incidence of mesothelioma in the world. More than 2,700 people in the United Kingdom are diagnosed…

  • Time to End the Debate on Genomic Testing in NSCLC

    Time to End the Debate on Genomic Testing in NSCLC

    By

    Evolving Standards of Care

    By Nathan Pennell, MD, PhD Posted: April 16, 2020 It’s an exciting time to be a thoracic oncologist. We live in an era of unprecedented discovery in medicine—and in oncology in particular—with basic scientific breakthroughs such as targetable driver oncogenes translating into highly effective treatments for patients in record time. In my relatively short career,…

  • PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

    PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

    By

    Diagnostic Oncology

    By Sylvie Lantuejoul, MD, PhD, and Mari Mino-Kenudson, MD Posted: April 16, 2020 Immune checkpoint inhibitors (ICI), which target the PD-1/PD-L1 axis with the aim of restoring anti-tumor immunity, are now available in routine clinical practice for the treatment of patients with advanced or metastatic NSCLC and SCLC. Several biomarkers have been reported to predict…

View ILCN Archives

Provider Resources

Popular Articles